{"id":32867,"date":"2024-07-03T12:29:05","date_gmt":"2024-07-03T12:29:05","guid":{"rendered":"https:\/\/ibima.eu\/estudio-multicentrico-abierto-de-extension-a-largo-plazo-de-los-estudios-de-fase-iii-bn29552-bn29553-de-crenezumab-en-pacientes-con-enfermedad-de-alzheimer\/"},"modified":"2024-07-03T12:29:05","modified_gmt":"2024-07-03T12:29:05","slug":"estudio-multicentrico-abierto-de-extension-a-largo-plazo-de-los-estudios-de-fase-iii-bn29552-bn29553-de-crenezumab-en-pacientes-con-enfermedad-de-alzheimer","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/estudio-multicentrico-abierto-de-extension-a-largo-plazo-de-los-estudios-de-fase-iii-bn29552-bn29553-de-crenezumab-en-pacientes-con-enfermedad-de-alzheimer\/","title":{"rendered":"ESTUDIO MULTIC\u00c9NTRICO ABIERTO DE EXTENSI\u00d3N A LARGO PLAZO DE LOS ESTUDIOS DE FASE III (BN29552\/BN29553) DE CRENEZUMAB EN PACIENTES CON ENFERMEDAD DE ALZHEIMER"},"content":{"rendered":"
PEDRO JES\u00daS SERRANO CASTRO – ENSAYO CLINICO COMERCIAL – ROCHE FARMA, S.A.<\/p>","protected":false},"excerpt":{"rendered":"
PEDRO JES\u00daS SERRANO CASTRO – ENSAYO CLINICO COMERCIAL – ROCHE FARMA, S.A.<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2263,2283],"tags":[],"class_list":["post-32867","post","type-post","status-publish","format-standard","hentry","category-ensayos-clinicos","category-ensayos-clinicos-c-01-ensayos-clinicos"],"acf":[],"yoast_head":"\n